Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Single Dose Study to Determine the Pharmacokinetic Profiles of Amoxicillin and Clavulanate in Pediatric Patients Receiving Either LP-001 or Augmentin ES-600 Orally

Next Previous
Trial Profile

A Single Dose Study to Determine the Pharmacokinetic Profiles of Amoxicillin and Clavulanate in Pediatric Patients Receiving Either LP-001 or Augmentin ES-600 Orally

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 10 Feb 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Amoxicillin/clavulanic acid (Primary)
  • Indications Abscess; Aspiration pneumonia; Bacterial infections; Cellulitis; Community-acquired pneumonia; Dental infections; Lymphadenitis; Otitis media; Peritonsillar abscess; Urinary tract infections
  • Focus Pharmacokinetics
  • Sponsors Kaizen Bioscience

Most Recent Events

  • 14 Nov 2024 According to Kaizen Bioscience Co media release, company announce plans for its first NDA submission in 1H 2025.
  • 05 Feb 2024 Planned End Date changed from 10 Mar 2023 to 10 Jun 2024.
  • 05 Feb 2024 Planned primary completion date changed from 10 Mar 2023 to 10 Jun 2024.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top